299 related articles for article (PubMed ID: 17677004)
1. Divergent evolution of human p53 binding sites: cell cycle versus apoptosis.
Horvath MM; Wang X; Resnick MA; Bell DA
PLoS Genet; 2007 Jul; 3(7):e127. PubMed ID: 17677004
[TBL] [Abstract][Full Text] [Related]
2. Functional evolution of the p53 regulatory network through its target response elements.
Jegga AG; Inga A; Menendez D; Aronow BJ; Resnick MA
Proc Natl Acad Sci U S A; 2008 Jan; 105(3):944-9. PubMed ID: 18187580
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional control of human p53-regulated genes.
Riley T; Sontag E; Chen P; Levine A
Nat Rev Mol Cell Biol; 2008 May; 9(5):402-12. PubMed ID: 18431400
[TBL] [Abstract][Full Text] [Related]
4. Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation.
Tomso DJ; Inga A; Menendez D; Pittman GS; Campbell MR; Storici F; Bell DA; Resnick MA
Proc Natl Acad Sci U S A; 2005 May; 102(18):6431-6. PubMed ID: 15843459
[TBL] [Abstract][Full Text] [Related]
5. Evolution of p53 transactivation specificity through the lens of a yeast-based functional assay.
Lion M; Raimondi I; Donati S; Jousson O; Ciribilli Y; Inga A
PLoS One; 2015; 10(2):e0116177. PubMed ID: 25668429
[TBL] [Abstract][Full Text] [Related]
6. Interactions of chromatin context, binding site sequence content, and sequence evolution in stress-induced p53 occupancy and transactivation.
Su D; Wang X; Campbell MR; Song L; Safi A; Crawford GE; Bell DA
PLoS Genet; 2015 Jan; 11(1):e1004885. PubMed ID: 25569532
[TBL] [Abstract][Full Text] [Related]
7. Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts.
Noureddine MA; Menendez D; Campbell MR; Bandele OJ; Horvath MM; Wang X; Pittman GS; Chorley BN; Resnick MA; Bell DA
PLoS Genet; 2009 May; 5(5):e1000462. PubMed ID: 19424414
[TBL] [Abstract][Full Text] [Related]
8. Identification of p53-target genes in Danio rerio.
Mandriani B; Castellana S; Rinaldi C; Manzoni M; Venuto S; Rodriguez-Aznar E; Galceran J; Nieto MA; Borsani G; Monti E; Mazza T; Merla G; Micale L
Sci Rep; 2016 Sep; 6():32474. PubMed ID: 27581768
[TBL] [Abstract][Full Text] [Related]
9. Chimpanzee, orangutan, mouse, and human cell cycle promoters exempt CCAAT boxes and CHR elements from interspecies differences.
Müller GA; Heissig F; Engeland K
Mol Biol Evol; 2007 Mar; 24(3):814-26. PubMed ID: 17205977
[TBL] [Abstract][Full Text] [Related]
10. Whole-genome cartography of p53 response elements ranked on transactivation potential.
Tebaldi T; Zaccara S; Alessandrini F; Bisio A; Ciribilli Y; Inga A
BMC Genomics; 2015 Jun; 16(1):464. PubMed ID: 26081755
[TBL] [Abstract][Full Text] [Related]
11. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.
Mirza A; Wu Q; Wang L; McClanahan T; Bishop WR; Gheyas F; Ding W; Hutchins B; Hockenberry T; Kirschmeier P; Greene JR; Liu S
Oncogene; 2003 Jun; 22(23):3645-54. PubMed ID: 12789273
[TBL] [Abstract][Full Text] [Related]
12. Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation.
Ashur-Fabian O; Avivi A; Trakhtenbrot L; Adamsky K; Cohen M; Kajakaro G; Joel A; Amariglio N; Nevo E; Rechavi G
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12236-41. PubMed ID: 15302922
[TBL] [Abstract][Full Text] [Related]
13. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
14. p53FamTaG: a database resource of human p53, p63 and p73 direct target genes combining in silico prediction and microarray data.
Sbisà E; Catalano D; Grillo G; Licciulli F; Turi A; Liuni S; Pesole G; De Grassi A; Caratozzolo MF; D'Erchia AM; Navarro B; Tullo A; Saccone C; Gisel A
BMC Bioinformatics; 2007 Mar; 8 Suppl 1(Suppl 1):S20. PubMed ID: 17430565
[TBL] [Abstract][Full Text] [Related]
15. Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants.
Greenblatt MS; Beaudet JG; Gump JR; Godin KS; Trombley L; Koh J; Bond JP
Oncogene; 2003 Feb; 22(8):1150-63. PubMed ID: 12606942
[TBL] [Abstract][Full Text] [Related]
16. Close sequence comparisons are sufficient to identify human cis-regulatory elements.
Prabhakar S; Poulin F; Shoukry M; Afzal V; Rubin EM; Couronne O; Pennacchio LA
Genome Res; 2006 Jul; 16(7):855-63. PubMed ID: 16769978
[TBL] [Abstract][Full Text] [Related]
17. Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals.
Han J; Flemington C; Houghton AB; Gu Z; Zambetti GP; Lutz RJ; Zhu L; Chittenden T
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11318-23. PubMed ID: 11572983
[TBL] [Abstract][Full Text] [Related]
18. Guinea pig p53 mRNA: identification of new elements in coding and untranslated regions and their functional and evolutionary implications.
D'erchia AM; Pesole G; Tullo A; Saccone C; Sbisà E
Genomics; 1999 May; 58(1):50-64. PubMed ID: 10331945
[TBL] [Abstract][Full Text] [Related]
19. Impact of Alu repeats on the evolution of human p53 binding sites.
Cui F; Sirotin MV; Zhurkin VB
Biol Direct; 2011 Jan; 6():2. PubMed ID: 21208455
[TBL] [Abstract][Full Text] [Related]
20. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
Inga A; Resnick MA
Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]